Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Established cell lines and patient-derived xenografts as equally relevant models of aggressive lymphomas

ABSTRACT: Established cell lines and patient-derived xenografts as equally relevant models of aggressive lymphomas

PROVIDER: PRJNA376701 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Established cell lines and patient-derived xenografts as equally relevant models of aggressive lymphomas

Project description:This SuperSeries is composed of the SubSeries listed below.

2017-02-24 | GSE95346 | GEO

Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas

Project description:Prednisone is anti-inflammatory glucocorticoid (GC), and GC-based therapy is most used combination chemotherapy for treating aggressive B-cell lymphomas. However, there are still gaps in our understanding of specific mechanism of GCâ€™s action for its cytotoxicity. By performing multi-omics approaches, we identified new GR targets and how these targets control the b-cell receptor signaling networks, providing a mechanistic framework upon which to base combination therapies.

2024-05-02 | PXD041891 | Pride

RNA sequencing/Gene expression studies of prednisolone in aggressive B-cell lymphomas [JC1]

Project description:We determined that glucocorticoid (prednisolone) treatment affects oncogenic signaling in aggressive B-cell lymphomas. We sought to measure gene expression change in aggressive B-cell lymphoma cells by RNA-sequencing following prednisolone treatment.

2023-03-17 | GSE226862 | GEO

DDX3X Loss is Associated with Aggressive Phenotypes in Non-Hodgkin’s Lymphomas

Project description:DDX3X Loss is Associated with Aggressive Phenotypes in Non-Hodgkin’s Lymphomas

| PRJNA687675 | ENA

Cleavage Under Targets and Release Using Nuclease (CUT&RUN) assay of glucocorticoid receptor (NR3C1) in aggressive B-cell lymphomas [JC3]

Project description:We determined that glucocorticoid treatment (prednisolone) affects oncogenic signaling in aggressive B-cell lymphomas. We sought to identify genes directly controlled and bound by NR3C1.

2023-03-17 | GSE226873 | GEO

Large B-Cell Lymphomas in Pediatric and Young Adults Display Clinically Relevant Molecular Features Distinguishable from Adult Counterparts [oncoscan]

Project description:Pediatric aggressive large B-cell lymphomas (LBCL) share morphological and phenotypic features with adult types but seem to have better prognosis. Additionally, a specific subtype carrying IRF4 translocations (LBCL-IRF4) has been recently identified in this age group.

2019-11-28 | GSE128215 | GEO

Large B-Cell Lymphomas in Pediatric and Young Adults Display Clinically Relevant Molecular Features Distinguishable from Adult Counterparts [cytoscan]

2019-11-28 | GSE128214 | GEO

Large B-Cell Lymphomas in Pediatric and Young Adults Display Clinically Relevant Molecular Features Distinguishable from Adult Counterparts [Nanostring]

2019-11-28 | GSE128293 | GEO

Large B-Cell Lymphomas in Pediatric and Young Adults Display Clinically Relevant Molecular Features Distinguishable from Adult Counterparts [SNP]

2019-11-28 | GSE128292 | GEO

RNA sequencing/Gene expression studies of prednisolone in aggressive B-cell lymphomas [JC1]

Project description:RNA sequencing/Gene expression studies of prednisolone in aggressive B-cell lymphomas [JC1]

| PRJNA941904 | ENA